GLIBENCLAMIDE - AN EXAMPLE HOW APPARENT ELIMINATION HALF-LIFE AND BIOAVAILABILITY MAY DEPEND ON ASSAY SENSITIVITY

Authors
SORGEL F ZAIGLER M MEDERT G KINZIGSCHIPPERS M KOHLER H PATZELTBATH A RUSING G FUHR U STAIB AH
Citation
F. Sorgel et al., GLIBENCLAMIDE - AN EXAMPLE HOW APPARENT ELIMINATION HALF-LIFE AND BIOAVAILABILITY MAY DEPEND ON ASSAY SENSITIVITY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 486-486
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Naunyn-Schmiedeberg's archives of pharmacology → ACNP
ISSN journal
00281298
Volume
355
Issue
4
Year of publication
1997
Supplement
S
Pages
486 - 486
Database
ISI
SICI code
0028-1298(1997)355:4<486:G-AEHA>2.0.ZU;2-G